Lineage Cell Therapeutics, Inc. Cost of Revenue
Lineage Cell Therapeutics, Inc. (LCTX) reported Cost of Revenue of $36.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2025-05-13
- Lineage Cell Therapeutics, Inc. cost of revenue for the quarter ending 2025-03-31 was $36.00K, a 63.27% decline year-over-year.
- Lineage Cell Therapeutics, Inc. cost of revenue for the quarter ending 2024-12-31 was $154.00K, a 39.84% decline year-over-year.
- Lineage Cell Therapeutics, Inc. cost of revenue for the quarter ending 2024-09-30 was $38.00K, a 77.51% decline year-over-year.
- Lineage Cell Therapeutics, Inc. cost of revenue for the quarter ending 2024-06-30 was $44.00K, a 65.35% decline year-over-year.
- Lineage Cell Therapeutics, Inc. cost of revenue for fiscal 2024 was $334.00K, a 50.22% decline from fiscal 2023.
- Lineage Cell Therapeutics, Inc. cost of revenue for fiscal 2023 was $671.00K, a 7.83% decline from fiscal 2022.
- Lineage Cell Therapeutics, Inc. cost of revenue for fiscal 2022 was $728.00K, a 48.95% decline from fiscal 2021.
- Lineage Cell Therapeutics, Inc. cost of revenue for fiscal 2021 was $1.43M, a 270.39% increase from fiscal 2020.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | $36.00K 10-Q · filed 2025-05-13 | $190.00K derived: sum of 2 quarters · filed 2025-05-13 | $228.00K derived: sum of 3 quarters · filed 2025-05-13 | $272.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2024-12-31 | $154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $192.00K derived: sum of 2 quarters · filed 2025-03-10 | $236.00K derived: sum of 3 quarters · filed 2025-03-10 | $334.00K 10-K · filed 2025-03-10 | ||||
| 2024-09-30 | $38.00K 10-Q · filed 2024-11-14 | $82.00K derived: sum of 2 quarters · filed 2024-11-14 | $180.00K 10-Q · filed 2024-11-14 | $436.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2024-06-30 | $44.00K 10-Q · filed 2024-08-08 | $142.00K 10-Q · filed 2024-08-08 | $398.00K derived: sum of 3 quarters · filed 2025-05-13 | $567.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2024-03-31 | $98.00K 10-Q · filed 2025-05-13 | $354.00K derived: sum of 2 quarters · filed 2025-05-13 | $523.00K derived: sum of 3 quarters · filed 2025-05-13 | $650.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $425.00K derived: sum of 2 quarters · filed 2025-03-10 | $552.00K derived: sum of 3 quarters · filed 2025-03-10 | $671.00K 10-K · filed 2025-03-10 | ||||
| 2023-09-30 | $169.00K 10-Q · filed 2024-11-14 | $296.00K derived: sum of 2 quarters · filed 2024-11-14 | $415.00K 10-Q · filed 2024-11-14 | $517.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $127.00K 10-Q · filed 2024-08-08 | $246.00K 10-Q · filed 2024-08-08 | $348.00K derived: sum of 3 quarters · filed 2024-08-08 | $583.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $119.00K 10-Q · filed 2024-05-09 | $221.00K derived: sum of 2 quarters · filed 2024-05-09 | $456.00K derived: sum of 3 quarters · filed 2024-05-09 | $671.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $337.00K derived: sum of 2 quarters · filed 2024-03-07 | $552.00K derived: sum of 3 quarters · filed 2024-03-07 | $728.00K 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | $235.00K 10-Q · filed 2023-11-09 | $450.00K derived: sum of 2 quarters · filed 2023-11-09 | $626.00K 10-Q · filed 2023-11-09 | $830.00K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $215.00K 10-Q · filed 2023-08-10 | $391.00K 10-Q · filed 2023-08-10 | $595.00K derived: sum of 3 quarters · filed 2023-08-10 | $1.58M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $176.00K 10-Q · filed 2023-05-11 | $380.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.36M derived: sum of 3 quarters · filed 2023-05-11 | $1.49M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.19M derived: sum of 2 quarters · filed 2023-03-09 | $1.31M derived: sum of 3 quarters · filed 2023-03-09 | $1.43M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $985.00K 10-Q · filed 2022-11-10 | $1.11M derived: sum of 2 quarters · filed 2022-11-10 | $1.22M 10-Q · filed 2022-11-10 | $1.34M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $125.00K 10-Q · filed 2022-08-11 | $237.00K 10-Q · filed 2022-08-11 | $351.00K derived: sum of 3 quarters · filed 2022-08-11 | $453.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $112.00K 10-Q · filed 2022-05-12 | $226.00K derived: sum of 2 quarters · filed 2022-05-12 | $328.00K derived: sum of 3 quarters · filed 2022-05-12 | $403.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $216.00K derived: sum of 2 quarters · filed 2022-03-10 | $291.00K derived: sum of 3 quarters · filed 2022-03-10 | $385.00K 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $102.00K 10-Q · filed 2021-11-10 | $177.00K derived: sum of 2 quarters · filed 2021-11-10 | $271.00K 10-Q · filed 2021-11-10 | $394.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $75.00K 10-Q · filed 2021-08-12 | $169.00K 10-Q · filed 2021-08-12 | $292.00K derived: sum of 3 quarters · filed 2021-08-12 | $406.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $94.00K 10-Q · filed 2021-05-13 | $217.00K derived: sum of 2 quarters · filed 2021-05-13 | $331.00K derived: sum of 3 quarters · filed 2021-05-13 | $438.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $237.00K derived: sum of 2 quarters · filed 2021-03-11 | $344.00K derived: sum of 3 quarters · filed 2021-03-11 | $412.00K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $114.00K 10-Q · filed 2020-11-04 | $221.00K derived: sum of 2 quarters · filed 2020-11-04 | $289.00K 10-Q · filed 2020-11-04 | $341.00K derived: sum of 4 quarters · filed 2020-11-04 | ||||
| 2019-06-30 | $107.00K 10-Q · filed 2020-08-06 | $175.00K 10-Q · filed 2020-08-06 | $227.00K derived: sum of 3 quarters · filed 2020-08-06 | $262.00K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $68.00K 10-Q · filed 2020-05-07 | $120.00K derived: sum of 2 quarters · filed 2020-05-07 | $155.00K derived: sum of 3 quarters · filed 2020-05-07 | $261.00K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $87.00K derived: sum of 2 quarters · filed 2020-03-12 | $193.00K derived: sum of 3 quarters · filed 2020-03-12 | $302.00K 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $35.00K 10-Q · filed 2019-11-12 | $141.00K derived: sum of 2 quarters · filed 2019-11-12 | $250.00K 10-Q · filed 2019-11-12 | $304.00K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $106.00K 10-Q · filed 2019-08-08 | $215.00K 10-Q · filed 2019-08-08 | $269.00K derived: sum of 3 quarters · filed 2019-08-08 | $321.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $109.00K 10-Q · filed 2019-05-09 | $163.00K derived: sum of 2 quarters · filed 2019-05-09 | $215.00K derived: sum of 3 quarters · filed 2019-05-09 | $220.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $106.00K derived: sum of 2 quarters · filed 2019-03-14 | $111.00K derived: sum of 3 quarters · filed 2019-03-14 | $168.00K 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | $52.00K 10-Q · filed 2018-11-08 | $57.00K derived: sum of 2 quarters · filed 2018-11-08 | $114.00K 10-Q · filed 2018-11-08 | $94.00K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $5.00K 10-Q · filed 2018-08-02 | $62.00K 10-Q · filed 2018-08-02 | $42.00K derived: sum of 3 quarters · filed 2018-08-02 | $100.00K derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $57.00K 10-Q · filed 2018-05-10 | $37.00K derived: sum of 2 quarters · filed 2018-05-10 | $95.00K derived: sum of 3 quarters · filed 2018-05-10 | $190.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $38.00K derived: sum of 2 quarters · filed 2018-03-15 | $133.00K derived: sum of 3 quarters · filed 2018-03-15 | $358.00K 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | $58.00K 10-Q · filed 2017-11-09 | $153.00K derived: sum of 2 quarters · filed 2017-11-09 | $378.00K 10-Q · filed 2017-11-09 | $528.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-06-30 | $95.00K 10-Q · filed 2017-08-09 | $320.00K 10-Q · filed 2017-08-09 | $470.00K derived: sum of 3 quarters · filed 2018-03-15 | $902.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | $225.00K 10-Q · filed 2017-05-10 | $375.00K derived: sum of 2 quarters · filed 2018-03-15 | $807.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.07M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $582.00K derived: sum of 2 quarters · filed 2018-03-15 | $842.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.11M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | $432.00K 10-Q · filed 2016-11-04 | $692.00K derived: sum of 2 quarters · filed 2016-11-04 | $957.00K 10-Q · filed 2016-11-04 | $1.18M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $260.00K 10-Q · filed 2016-08-09 | $525.00K 10-Q · filed 2016-08-09 | $747.00K derived: sum of 3 quarters · filed 2017-03-16 | $978.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $264.00K 10-Q · filed 2016-05-10 | $264.17K 10-Q · filed 2015-05-08 | $487.00K derived: sum of 2 quarters · filed 2017-03-16 | $718.00K derived: sum of 3 quarters · filed 2017-03-16 | $970.00K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $454.00K derived: sum of 2 quarters · filed 2017-03-16 | $706.00K derived: sum of 3 quarters · filed 2017-03-16 | $837.00K 10-K · filed 2017-03-16 | $837.05K 10-K · filed 2015-03-11 | |||
| 2014-09-30 | $231.00K 10-Q · filed 2015-11-09 | $230.90K 10-Q · filed 2014-11-07 | $483.00K derived: sum of 2 quarters · filed 2015-11-09 | $614.00K 10-Q · filed 2015-11-09 | $614.08K 10-Q · filed 2014-11-07 | $837.68K derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | $252.00K 10-Q · filed 2015-08-10 | $251.26K 10-Q · filed 2014-08-11 | $383.00K 10-Q · filed 2015-08-10 | $383.18K 10-Q · filed 2014-08-11 | $606.68K derived: sum of 3 quarters · filed 2016-03-15 | $813.36K derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-03-31 | $131.91K 10-Q · filed 2015-05-08 | $354.68K derived: sum of 2 quarters · filed 2016-03-15 | $561.36K derived: sum of 3 quarters · filed 2016-03-15 | $742.17K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $222.76K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $429.44K derived: sum of 2 quarters · filed 2016-03-15 | $610.25K derived: sum of 3 quarters · filed 2016-03-15 | $793.00K 10-K · filed 2016-03-15 | $792.66K 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $206.68K 10-Q · filed 2014-11-07 | $387.49K derived: sum of 2 quarters · filed 2014-11-07 | $570.24K 10-Q · filed 2014-11-07 | $730.59K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-06-30 | $180.81K 10-Q · filed 2014-08-11 | $363.56K 10-Q · filed 2014-08-11 | $523.91K derived: sum of 3 quarters · filed 2015-03-11 | $693.65K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-03-31 | $182.75K 10-Q · filed 2014-05-12 | $343.10K derived: sum of 2 quarters · filed 2015-03-11 | $512.84K derived: sum of 3 quarters · filed 2015-03-11 | $596.76K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2012-12-31 | $160.35K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $330.09K derived: sum of 2 quarters · filed 2015-03-11 | $414.01K derived: sum of 3 quarters · filed 2015-03-11 | $434.27K 10-K · filed 2015-03-11 | ||||
| 2012-09-30 | $169.73K 10-Q · filed 2013-11-12 | $253.65K derived: sum of 2 quarters · filed 2013-11-12 | $273.92K 10-Q · filed 2013-11-12 | $294.51K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | $83.92K 10-Q · filed 2013-08-09 | $105.50K 10-Q · filed 2013-08-09 | $124.78K derived: sum of 3 quarters · filed 2014-03-17 | $143.29K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | $20.27K 10-Q · filed 2013-05-10 | $40.86K derived: sum of 2 quarters · filed 2014-03-17 | $59.37K derived: sum of 3 quarters · filed 2014-03-17 | $84.19K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | $20.59K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $39.10K derived: sum of 2 quarters · filed 2014-03-17 | $63.92K derived: sum of 3 quarters · filed 2014-03-17 | $79.40K 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $18.52K 10-Q · filed 2012-11-09 | $43.33K derived: sum of 2 quarters · filed 2012-11-09 | $58.81K 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | $24.82K 10-Q · filed 2012-08-09 | $24.83K 10-Q · filed 2012-08-09 | ||||||
| 2010-12-31 | $27.72K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |